CGON vs REGN: Which Stock is Better?
Side-by-side comparison of CG Oncology, Inc. Common stock and Regeneron Pharmaceuticals Inc in 2026
CGON
CG Oncology, Inc. Common stock
—
REGN
Regeneron Pharmaceuticals Inc
$654.27
Key Metrics Comparison
| Metric | CGON | REGN | Winner |
|---|---|---|---|
| Market Cap | $4.74B | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CGON
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGON or REGN a better investment?
Comparing CGON and REGN: CG Oncology, Inc. Common stock has a market cap of $4.74B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGON and REGN?
CGON (CG Oncology, Inc. Common stock) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGON or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGON or REGN?
Both CGON and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CGON or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CGON or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $4.74B for CGON.
Should I buy CGON or REGN in 2026?
Both CGON and REGN have investment merit. CGON trades at $N/A while REGN trades at $654.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGON and REGN stock?
Key differences: Market Cap ($4.74B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CGON or REGN in 2026?
The choice between CGON and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CGON and REGN?
CGON (CG Oncology, Inc. Common stock) has a market cap of $4.74B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.